POT1 and neoplasm: Therefore, oncogenic POT1 variants predominantly appear to drive cancer through telomere lengthening that enhances the proliferative capacity of incipient tumor cells and enables acquisition of cooperating mutations required for cancer progression rather than through telomere deprotection and fragility [11].